According to IMARC Group’s latest report, titled “Europe Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the market exhibited strong growth during 2015-2020. Generic drugs refer to pharmaceutical products that have an equivalent therapeutic effect as their branded counterparts. They are identical to the innovator drug in terms of strength, quality, safety, dosage route of administration, etc. Unlike branded drugs, generic drugs are cost-efficient and do not require hefty investments in marketing campaigns or clinical studies.
Request for a PDF sample of this report: https://www.imarcgroup.com/europe-generic-drug-market/requestsample
In Europe, various government bodies are undertaking several initiatives to maintain a stable supply of medicines and support the Supplementary Protection Certificate (SPC) manufacturing waiver, which is primarily driving the generic drug market. Additionally, limited production costs of generic drugs are attracting key manufacturers to make capital investments in the generic drug industry. In addition to this, sedentary consumer lifestyles, inflating income levels, and increasing prevalence of lifestyle and chronic diseases, such as cancer, diabetes, obesity, etc., are also augmenting the market growth. Furthermore, the escalating geriatric population and increasing healthcare expenditures are expected to fuel the Europe generic drug market over the forecasted period. Looking forward, IMARC Group expects the Europe generic drug market to continue its strong growth during 2021-2026.
Checkout Now: https://www.imarcgroup.com/checkout?id=3276&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Breakup by Segment:
- Unbranded Generics
- Branded Generics
Breakup by Therapy Area:
- Central Nervous System
Breakup by Drug Delivery:
Breakup by Distribution Channel:
Breakup by Country:
- United Kingdom
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/europe-generic-drug-market
Note: We are updating our reports, If you want the report with the latest primary and secondary data (2021-2026) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800